[KIR/HLA ligand matching and acute rejection after kidney transplantation].

人类白细胞抗原 基因型 移植 肾移植 配体(生物化学) 免疫学 入射(几何) 医学 生物 内科学 受体 基因 遗传学 抗原 物理 光学
作者
Li-xin Yu,Fei Xiao,Lulu Xiao,Min Luo,Shao-jie Fu,Yibin Wang,Yun Miao
出处
期刊:PubMed 卷期号:30 (2): 288-91 被引量:2
链接
标识
摘要

To explore the effect of KIR/HLA ligand matching which mediates activated or inhibitory signal pathways on acute rejection (AR) after kidney transplantation.HLA and KIR genotype assortments were analyzed in 53 donor/recipient pairs of kidney transplantation. The recipients were divided into AR group (GI, n=19) and stable renal function group (GII, n=34) based on the early graft function. The impact of donor HLA, recipient KIR and distinct KIR/HLA class I ligand combinations on acute rejection after kidney transplantation was studied.No significant differences were found in donor HLA-C1/2, HLA-A3, HLA-A11, or HLA-Bw4 between GI and GII groups. The frequency for KIR2DL2/2DS2 and KIR genotype assortment (AA) of the recipients in GI group were significantly lower than that in GII group (26.3% vs 55.9%, P=0.038; 31.6% vs 67.6%, P=0.011). The incidence of AR was significantly lower in donor HLA-C1/1 than in non-C1/1 (31.6% vs 46.7%, P>0.05), and lower in recipient KIR genotype assortment (AA) than in non-AA (20.7% vs 52.2%, P=0.011). A significant higher number of matches for the KIR2DL2/ HLA-C1 and KIR2DL3/HLA-C1 were observed in GII group (P=0.030, P=0.028).Distinct KIR/HLA class I ligand combinations between the donor and recipient (such as KIR2DL2/ HLA-C1 and KIR2DL3/HLA-C1) may reduce the incidence of AR. A good KIR/HLA class I ligand matching will benefit the survival of the renal allograft.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
zt1812431172完成签到,获得积分10
刚刚
hyc完成签到,获得积分10
刚刚
小葡萄完成签到,获得积分10
刚刚
嘻嘻哈哈应助纳兰嫣然采纳,获得10
刚刚
科研通AI6.2应助兴奋晟睿采纳,获得10
刚刚
刚刚
xxxyyywww发布了新的文献求助10
刚刚
云朵完成签到,获得积分10
1秒前
新嘟发布了新的文献求助10
1秒前
哈哈哈哈完成签到,获得积分10
1秒前
烂漫的烙完成签到,获得积分10
2秒前
wbb发布了新的文献求助10
2秒前
kk完成签到,获得积分10
2秒前
若风完成签到,获得积分10
2秒前
Aulalala完成签到,获得积分10
3秒前
裴仰纳完成签到 ,获得积分10
3秒前
英俊的铭应助111采纳,获得10
3秒前
sunsun完成签到,获得积分10
3秒前
Wayi完成签到,获得积分10
4秒前
zephyr完成签到 ,获得积分10
4秒前
4秒前
4秒前
smy发布了新的文献求助10
4秒前
N7完成签到,获得积分20
4秒前
zissx发布了新的文献求助10
5秒前
田田田田发布了新的文献求助10
5秒前
5秒前
萼绿华发布了新的文献求助10
5秒前
kk发布了新的文献求助10
5秒前
奋斗灵珊完成签到,获得积分10
6秒前
6秒前
吉如天发布了新的文献求助10
7秒前
张张发布了新的文献求助10
7秒前
啊哈哈完成签到,获得积分10
8秒前
小鱼完成签到,获得积分10
8秒前
qqqqqqqq发布了新的文献求助10
9秒前
9秒前
SYX完成签到 ,获得积分10
9秒前
9秒前
高分求助中
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
久松真一著作集〈第5巻〉禅と芸術 500
Fundamentals of Modern Mathematics: A Practical Review (Dover Books on Mathematics) 500
Cold War Transcended: Australia's China Policy, 1949-1990 470
Cybercrime: The Transformation of Crime in the Information Age, 2nd Edition 400
Moore's Clinically Oriented Anatomy 10th Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6616397
求助须知:如何正确求助?哪些是违规求助? 8380952
关于积分的说明 17929535
捐赠科研通 5785038
什么是DOI,文献DOI怎么找? 2959545
邀请新用户注册赠送积分活动 1934761
关于科研通互助平台的介绍 1838848